MARKET

PMD

PMD

Psychemedics Corp
NASDAQ
5.80
-0.03
-0.51%
Opening 11:01 11/29 EST
OPEN
5.80
PREV CLOSE
5.83
HIGH
5.80
LOW
5.80
VOLUME
714
TURNOVER
638
52 WEEK HIGH
8.46
52 WEEK LOW
5.73
MARKET CAP
32.74M
P/E (TTM)
-16.0398
1D
5D
1M
3M
1Y
5Y
Psychemedics GAAP EPS of -$0.02, revenue of $6.5M
Seekingalpha · 11/09 22:40
Psychemedics declares $0.07 dividend
Seekingalpha · 11/09 22:08
-- Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Reports Q3 Revenue $6.5M
-- Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Reports Q3 Revenue $6.5M
MT Newswires · 11/09 17:20
One Psychemedics Corporation (NASDAQ:PMD) insider upped their stake by 13% in the previous year
From what we can see, insiders were net buyers in Psychemedics Corporation's ( NASDAQ:PMD ) during the past 12 months...
Simply Wall St. · 11/07 12:38
Don't Race Out To Buy Psychemedics Corporation (NASDAQ:PMD) Just Because It's Going Ex-Dividend
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Psychemedics...
Simply Wall St. · 08/18 12:12
BRIEF-Psychemedics Q1 Loss Per Share $0.06
BRIEF-Psychemedics Q1 Loss Per Share $0.06
Reuters · 08/09 21:37
Psychemedics GAAP EPS of -$0.06, revenue of $6.51M
Psychemedics press release (<span class="tic...
Seekingalpha · 08/09 21:26
Psychemedics Q2 EPS $(0.06) Down From $0.02 YoY, Sales $6.50M Up From $6.09M YoY
Psychemedics (NASDAQ:PMD) reported quarterly losses of $(0.06) per share. This is a 400 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $6.50 million in sales this
Benzinga · 08/09 21:23
More
About PMD
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The Company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The Company markets its corporate drug testing services through its own sales force, distributors and webinars. The Company markets its home drug testing service, PDT-90, through the Internet.

Webull offers kinds of Psychemedics Corp. stock information, including NASDAQ:PMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PMD stock methods without spending real money on the virtual paper trading platform.